Side effects are minimal, typically limited to mild injection site redness
Venlafaxine ER blocks the norepinephrine transporter in the brain of patients with major depressive disorder: a PET study using [18F]FMeNER-D2
According to the telehealth consent published by OpenLoop Healthcare Partners, PC, the licensed medical group partnering with FeelGood, the FDA does not approve, review, or evaluate compounded medications for safety, effectiveness, or quality
Similarly, a few adverse experiences of moderate intensity were reported following intramuscular dosing (two headaches and rhinitis
Risk increases when: products are not sourced through reliable medical supply chains sterility is uncertain aftercare guidance is inconsistent Infections can range from mild cellulitis to abscesses that require antibiotics, drainage, and follow-up